Beth A. Dy

1.5k citations

20 papers · 1.1k indexed · h-index 14

Biochemistry top 0.5%
- Blood transfusion and management 16
Management of Technology and Innovation top 0.5%
- Blood donation and transfusion practices 17
Critical Care and Intensive Care Medicine top 2%
- Trauma, Hemostasis, Coagulopathy, Resuscitation 2
Hematology top 5%
- Platelet Disorders and Treatments 3
Parasitology top 10%
Public Health, Environmental and Occupational Health
- Organ Donation and Transplantation 4
Genetics
- Hemoglobinopathies and Related Disorders 4
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
Clinical Biochemistry
- Bacterial Identification and Susceptibility Testing 2

Co-authors: Anne F. Eder Richard J. Benjamin Edward P. Notari Roger Y. Dodd Jean M. Kennedy Annie Strupp Stephen J. Wagner R. Herron
Cited by: Biochemistry Management of Technology and Innovation Critical Care and Intensive Care Medicine
Journals: Transfusion (17 papers)Journal of Clinical Apheresis (1 paper)Vox Sanguinis (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

Beth A. Dy

20 papers receiving 1.0k citations

Peers

Countries citing papers authored by Beth A. Dy

Since Specialization

Citations

This map shows the geographic impact of Beth A. Dy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth A. Dy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth A. Dy more than expected).

Fields of papers citing papers by Beth A. Dy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth A. Dy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth A. Dy. The network helps show where Beth A. Dy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Beth A. Dy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beth A. Dy Line = papers co-authored together Beth A. Dy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The operational and financial impact of adding anaerobic screening of platelets Transfusion ·Jorge A. Rios,Douglas Raine,Beth A. Dy,Pampee P. Young	2023	1
2	The safety of COVID‐19 convalescent plasma donation: A multi‐institutional donor hemovigilance study Transfusion ·Aeko Pria Utama FR,Srijana Rajbhandary,Nancy L. Van Buren,Mark Fung,Fadrique fl. 1472-1518 impresor Biel de Basilea,Joy Fridey,Beth A. Dy,Alyssa Ziman,George B. Schreiber,Richard R. Gammon,Rita A. Reik,James R. Stubbs,Camille M. van Buskirk,Hany Kamel,Evy Kulka,Michelle P. Zeller,Jerome L. Gottschall	2021	5
3	Adoption trends of point of issue Verax PGD rapid test for bacterial screening of platelets between 2013 and 2018 among hospitals supplied by the American Red Cross and impact on platelet availability Transfusion ·Jorge A. Rios,M Z Bumbasirevic,Beth A. Dy,Pampee P. Young	2020	2
4	Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions Transfusion ·Anne F. Eder,Beth A. Dy,Noureddine Taj,Stephen J. Wagner,Susan L. Stramer,Eoghan O’Neill,R. Herron	2017	34
5	Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion‐related acute lung injury risk from apheresis platelets Transfusion ·Anne F. Eder,Beth A. Dy,Eoghan O’Neill	2016	14
6	Clostridium perfringens in apheresis platelets: an unusual contaminant underscores the importance of clinical vigilance for septic transfusion reactions (CME) Transfusion ·Anne F. Eder,A. Eisenschenk,Achmad Junaidi,Beth A. Dy,Richard J. Benjamin,Stephen J. Wagner	2013	16
7	Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results Vox Sanguinis ·Richard J. Benjamin,Beth A. Dy,Isabel Feitosa Dos Santos,Anne F. Eder,Stephen J. Wagner	2013	45
8	The residual risk of transfusion‐related acute lung injury at the American Red Cross (2008‐2011): limitations of a predominantly male‐donor plasma mitigation strategy Transfusion ·Anne F. Eder,Beth A. Dy,Isabel Feitosa Dos Santos,A. Gournay,Richard J. Benjamin	2012	56
9	Improved safety for young whole blood donors with new selection criteria for total estimated blood volume Transfusion ·Anne F. Eder,Beth A. Dy,Jean M. Kennedy,Isabel Feitosa Dos Santos,E Hattori,G. Hoorneman,Richard J. Benjamin	2011	39
10	Donor survey to assess facial flushing during automated red cell collections and medication use Journal of Clinical Apheresis ·Anne F. Eder,Mohamed L. Bouaré,Beth A. Dy,R. Herron,Mary Ellen Wissel,R. Wallace Henry,Mary Jo Drew,David Mair	2011	1
11	Skin disinfection with a single‐step 2% chlorhexidine swab is more effective than a two‐step povidone‐iodine method in preventing bacterial contamination of apheresis platelets Transfusion ·Richard J. Benjamin,Beth A. Dy,Md. Zahidul Islam,Muzaffar Hussain,Anne F. Eder	2010	46
12	Effective reduction of transfusion‐related acute lung injury risk with male‐predominant plasma strategy in the American Red Cross (2006‐2008) Transfusion ·Anne F. Eder,R. Herron,Annie Strupp,Beth A. Dy,Jennifer White,Edward P. Notari,Roger Y. Dodd,Richard J. Benjamin	2010	120
13	TRANSFUSION COMPLICATIONS: Transfusion‐transmitted Babesia microti identified through hemovigilance Transfusion ·Laura Tonnetti,Anne F. Eder,Beth A. Dy,Jean M. Kennedy,Patricia Pisciotto,Richard J. Benjamin,David A. Leiby	2009	70
14	Limiting and detecting bacterial contamination of apheresis platelets: inlet‐line diversion and increased culture volume improve component safety Transfusion ·Anne F. Eder,Jean M. Kennedy,Beth A. Dy,Edward P. Notari,Robert Skeate,Gary J. Bachowski,David Mair,K. B�ttner,Stephen J. Wagner,Roger Y. Dodd,Richard J. Benjamin	2009	92
15	The ARC Hemovigilance Program: advancing the safety of blood donation and transfusion Immunohematology ·Anne F. Eder,Beth A. Dy,James C. Barton,John Kennedy,Richard J. Benjamin	2009	13
16	The relative safety of automated two‐unit red blood cell procedures and manual whole‐blood collection in young donors Transfusion ·Richard J. Benjamin,Beth A. Dy,Jean M. Kennedy,Edward P. Notari,Anne F. Eder	2009	13
17	The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006 Transfusion ·Anne F. Eder,Beth A. Dy,Jean M. Kennedy,Edward P. Notari,Annie Strupp,Mary Ellen Wissel,N. Wang,Joan Gibble,W Sugar Creek,Bruce Newman,Linda A. Chambers,Christopher D. Hillyer,Richard J. Benjamin	2008	109
18	Bacterial contamination of whole blood–derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross Transfusion ·Richard J. Benjamin,J. R. Faillace,Beth A. Dy,Jean M. Kennedy,Patricia Pisciotto,Suneeti Sapatnekar,Ankita Maity,Anne F. Eder	2008	52
19	Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004‐2006) Transfusion ·Anne F. Eder,Jean M. Kennedy,Beth A. Dy,Edward P. Notari,John Weiss,Chyang T. Fang,Stephen J. Wagner,Roger Y. Dodd,Richard J. Benjamin	2007	171
20	Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross Transfusion ·Anne F. Eder,R. Herron,Annie Strupp,Beth A. Dy,Edward P. Notari,Linda A. Chambers,Roger Y. Dodd,Richard J. Benjamin	2007	182

About Beth A. Dy

Beth A. Dy is a scholar working on Biochemistry, Management of Technology and Innovation, Applied Microbiology and Biotechnology, Genetics and Hematology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Blood donation and transfusion practices (17 papers), Blood transfusion and management (16 papers), Organ Donation and Transplantation (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Platelet Disorders and Treatments (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Biochemistry (765 citations), Management of Technology and Innovation (560 citations), Critical Care and Intensive Care Medicine (264 citations), Hematology (294 citations) and Parasitology (61 citations). Beth A. Dy has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Anne F. Eder, Richard J. Benjamin, Edward P. Notari, Roger Y. Dodd, Jean M. Kennedy, Annie Strupp, Stephen J. Wagner, R. Herron, Linda A. Chambers and Chyang T. Fang. Their work appears in journals such as Transfusion, Journal of Clinical Apheresis, Vox Sanguinis and Immunohematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact